<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03652597</url>
  </required_header>
  <id_info>
    <org_study_id>NL63092.041.17</org_study_id>
    <nct_id>NCT03652597</nct_id>
  </id_info>
  <brief_title>Neuro-Cardiac-Guided Transcranial Magnetic Stimulation: Replication and Dose-response.</brief_title>
  <official_title>Neuro-Cardiac-Guided Transcranial Magnetic Stimulation: a Method to Probe the Depression Network. Replication and Dose-response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Utrecht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research institute Brainclinics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Utrecht University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autonomic regulation is disturbed in patients with major depressive disorder (MDD), indicated
      by a higher heart rate (HR) and lower heart rate variability (HRV). Moreover, the heart seems
      to be functionally connected via the vagus nerve (VN) to other brain structures that are
      dysregulated in depression, such as the subgenual anterior cingulate cortex (sgACC), and the
      dorsolateral prefrontal cortex (DLPFC), suggesting dysregulated network function in MDD. In
      line with this network dysregulation hypothesis of MDD, optimal transcranial magnetic
      stimulation (TMS) sites are currently thought to be those that show functional connectivity
      to the sgACC such as the DLPFC and multiple studies have shown that stimulation of the DLPFC,
      sgACC and nervus vagus decreased heart rate, suggestive of parasymphatetic action. It is
      hypothesized that this influence on parasympathetic activity can be used as a functional
      outcome measure reflecting adequate targeting of the DLPFC-sgACC network, similar to the
      motor evoked potential (MEP) as functional key measure for primary motor cortex stimulation.
      Recently, a pilot study was conducted, proposing a new functional neuronavigation method for
      localizing the frontal area representation of DLPFC-sgACC connectivity using HR, called:
      Neuro-Cardiac-Guided TMS (NCG-TMS), which is being replicated in the current study. .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 6, 2018</start_date>
  <completion_date type="Actual">May 2, 2019</completion_date>
  <primary_completion_date type="Actual">May 2, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate during stimulation, converted to RR intervals</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Left</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are ascribed to left hemispheric stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are ascribed to right hemispheric stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial magnetic stimulation (TMS)</intervention_name>
    <description>Subjects receive TMS on several cortical brain locations, while recording the heart rate.</description>
    <arm_group_label>Left</arm_group_label>
    <arm_group_label>Right</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Between ages 18-60

        Exclusion Criteria:

          -  No prior experience with epilepsy

          -  No pregnancy

          -  No metal in the head

          -  No cochlear implants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martijn Arns, Phd.</last_name>
    <role>Study Director</role>
    <affiliation>Research institute Brainclinics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research institute Brainclinics</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6524AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>August 28, 2018</study_first_submitted>
  <study_first_submitted_qc>August 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <last_update_submitted>May 14, 2019</last_update_submitted>
  <last_update_submitted_qc>May 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Utrecht University</investigator_affiliation>
    <investigator_full_name>Tabitha Iseger</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Target engagement</keyword>
  <keyword>TMS</keyword>
  <keyword>Heart-brain pathway</keyword>
  <keyword>Depression</keyword>
  <keyword>Neuromodulation</keyword>
  <keyword>DLPFC</keyword>
  <keyword>Heart rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

